13F-HR filed by PFM Health Sciences, LP
PFM Health Sciences, LP filed this 13F-HR for the quarter ended 2015-12-31, filed 2016-02-16, with 67 holding rows worth $3,291,094,000.
- Accession
- 0001144204-16-082684
- Filer
- CIK 1442756
- Filed
- 2016-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2015
A holdings report, 67 entries on the cover page, a total value of $3,291,094,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,291,094,000 with VALUE read as thousands by filing date, 13F file number 028-13169. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 110122108 | COM | 2,853,840 | $196,316,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 2,267,196 | $193,063,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 492,459 | $153,893,000 | thousands by filing date | |
| PALO ALTO NETWORKS INC | 697435105 | COM | 818,852 | $144,233,000 | thousands by filing date | |
| AERCAP HOLDINGS NV SHS | N00985106 | Stock | 2,922,514 | $126,136,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,860,952 | $122,153,000 | thousands by filing date | |
| Alphabet Inc. Reg. Shares A | 02079K305 | COM | 137,536 | $107,004,000 | thousands by filing date | |
| Amazon.com, Inc | 023135106 | COM | 147,060 | $99,396,000 | thousands by filing date | |
| VULCAN MATLS CO COM | 929160109 | Stock | 1,023,285 | $97,181,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 1,174,098 | $92,730,000 | thousands by filing date | |
| Charles Schwab Corp | 808513105 | COM | 2,779,577 | $91,531,000 | thousands by filing date | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 1,051,826 | $85,482,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 2,066,547 | $77,165,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 2,777,464 | $74,158,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 2,078,440 | $72,745,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 511,850 | $71,946,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 573,905 | $68,576,000 | thousands by filing date | |
| TEXTRON INC COM | 883203101 | Stock | 1,573,009 | $66,082,000 | thousands by filing date | |
| LAM RESEARCH CORP | 512807108 | COM | 804,833 | $63,920,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 1,890,030 | $62,428,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122908 | CALL | 877,100 | $60,336,000 | thousands by filing date | call |
| SYNCHRONYFINL | 87165B103 | STOK | 1,969,737 | $59,900,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 2,374,797 | $57,826,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 523,340 | $56,584,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 1,287,443 | $55,077,000 | thousands by filing date | |
| META PLATFORMS INC CL A | 30303M102 | COM | 524,747 | $54,920,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 1,416,728 | $54,813,000 | thousands by filing date | |
| FORTUNE BRANDS INNOVATIONS INC COM | 34964C106 | Stock | 897,740 | $49,825,000 | thousands by filing date | |
| Netflix, Inc | 64110L106 | COM | 426,764 | $48,813,000 | thousands by filing date | |
| BLACKROCK INC CL A COM | 09247X101 | COM | 129,200 | $43,995,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 667,840 | $42,889,000 | thousands by filing date | |
| ServiceNow,Inc. | 81762P102 | COM | 481,927 | $41,716,000 | thousands by filing date | |
| MACQUARIE INFRASTRUCTURE HOLDI | 55608B105 | COMMON UNITS | 563,552 | $40,914,000 | thousands by filing date | |
| Home Depot, Inc | 437076102 | COM | 276,778 | $36,604,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 587,956 | $35,354,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 5,124,148 | $34,588,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 556,433 | $34,287,000 | thousands by filing date | |
| UNITED RENTALS INC COM | 911363109 | Stock | 396,663 | $28,774,000 | thousands by filing date | |
| Microsoft Corp | 594918104 | COM | 492,143 | $27,304,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 401,817 | $27,175,000 | thousands by filing date | |
| CHARTER COMMUNICATION - A | 16117M305 | COM | 145,325 | $26,609,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 1,008,232 | $26,557,000 | thousands by filing date | |
| THERAVANCE INC | 88338T104 | COMMON STOCK | 2,311,681 | $24,365,000 | thousands by filing date | |
| HORTONWORKS INC | 440894103 | COM | 1,103,877 | $24,175,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 703,987 | $22,760,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 174,697 | $20,551,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 159,895 | $19,149,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 896,634 | $17,088,000 | thousands by filing date | |
| RITEAID CORP | 767754104 | COM | 1,937,467 | $15,190,000 | thousands by filing date | |
| ZELTIQ AESTHETICS INC | 98933Q108 | COM | 513,884 | $14,661,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 176,038 | $14,418,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 72,627 | $14,324,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,494,169 | $12,551,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464900 | CALL | 325,100 | $11,379,000 | thousands by filing date | call |
| MYOKARDIA INC | 62857M105 | COM | 698,694 | $10,243,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164AB0 | NOTE 2.750%12/0 | 16,788,000 | $10,034,000 | thousands by filing date | principal |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 282,420 | $8,526,000 | thousands by filing date | |
| DIMENSION THERAPEUTICS INC | 25433V105 | COM | 815,359 | $8,385,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 66,187 | $6,697,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 150,684 | $6,626,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464AB6 | NOTE 2.500% 9/1 | 4,637,000 | $3,988,000 | thousands by filing date | principal |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 172,638 | $3,964,000 | thousands by filing date | |
| ATLASSIAN CORP | G06242104 | CL A | 98,357 | $2,959,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 46,531 | $2,504,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 40,850 | $2,382,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 119,092 | $1,977,000 | thousands by filing date | |
| MAXLINEAR INC | 57776J100 | COM | 81,443 | $1,200,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-16-082684 | this filing | 2016-02-16 | acceptance time not in the bulk data set |